Please enable JS

MedPage Today – Providers, Patients Demand Transparency for Biosimilar Use

7/ 16

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Jul 16, 2015

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

MedPage Today – Providers, Patients Demand Transparency for Biosimilar Use

WASHINGTON — With biosimilar drugs now reaching the U.S. market, patients and providers are demanding greater transparency and oversight from both federal and state regulators. A primary concern is that third party payers may substitute one medication for another without a patient’s knowledge or consent.

Click Here to read more


 

Font Resize